Performance of Bioresorbable Scaffold in Primary Percutaneous Intervention of ST Elevation Myocardial Infarct
A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 120 participants.
Also called NCT02067091
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 120 participants
- Sponsor
- Registry
-
NCT02067091
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Denmark, Norway
- Registry status
- Unknown status
Technical summary
Registry record NCT02067091. Randomized; no masking; primary purpose treatment. Start 2014-08 (registry gives no type); primary completion 2018-04 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Performance of Bioresorbable Scaffold in Primary Percutaneous Intervention of ST Elevation Myocardial Infarct
- Acronym
- BVS in STEMI
- Condition
- Acute ST Segment Elevation Myocardial Infarction
- Intervention (Device)
- stent implant in a coronary artery
- Lead sponsor
- Haukeland University Hospital
- Collaborator
- Aarhus University Hospital Skejby
- Collaborator
- Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
- Collaborator
- Oslo University Hospital
- Collaborator
- St. Olavs Hospital
- Collaborator
- University Hospital of North Norway
- Collaborator
- Feiring
Record details
- Record id
cardio:ct-nct02067091- Content hash
6c6ac8de2cdf2f05f4566e10efb5a822d6de46db36414b2219561032c56dc0d9